[HTML][HTML] Beyond TCR signaling: emerging functions of Lck in cancer and immunotherapy

U Bommhardt, B Schraven, L Simeoni - International journal of molecular …, 2019 - mdpi.com
In recent years, the lymphocyte-specific protein tyrosine kinase (Lck) has emerged as one of
the key molecules regulating T-cell functions. Studies using Lck knock-out mice or Lck …

[HTML][HTML] Transcriptome-based network analysis unveils eight immune-related genes as molecular signatures in the immunomodulatory subtype of triple-negative …

J Zhang, L Wang, X Xu, X Li, W Guan, T Meng… - Frontiers in …, 2020 - frontiersin.org
Objective: Triple-negative breast cancer (TNBC) is a high heterogeneity cancer. The
identification of genomic aberrations that drive each of the TNBC subtypes may predict the …

[HTML][HTML] A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells

Z Wang, M Peng - Scientific reports, 2021 - nature.com
Abstract Lymphocyte cytosolic protein 2 (LCP2) is one of the SLP-76 family of adapters,
which are critical intermediates in signal cascades downstream of several receptors. LCP2 …

Epigenetic programming underpins B‐cell dysfunction in peanut and multi‐food allergy

S Imran, MR Neeland, J Koplin… - Clinical & …, 2021 - Wiley Online Library
Abstract Objective Rates of IgE‐mediated food allergy (FA) have increased over the last few
decades, and mounting evidence implicates disruption of epigenetic profiles in various …

Lymphocyte cytosolic protein 2 is a novel prognostic marker in lung adenocarcinoma

Y Huo, K Zhang, S Han, Y Feng… - Journal of International …, 2021 - journals.sagepub.com
Objective Lymphocyte cytosolic protein 2 (LCP2) is often ectopically expressed in various
human tumors. However, the clinical significance and role of LCP2 in lung adenocarcinoma …

B cell receptor signaling proteins as biomarkers for progression of CLL requiring first-line therapy

MYL Vervoordeldonk, PJ Hengeveld… - Leukemia & …, 2024 - Taylor & Francis
The molecular landscape of chronic lymphocytic leukemia (CLL) has been extensively
characterized, and various potent prognostic biomarkers were discovered. The genetic …

[HTML][HTML] Identification of useful biomolecular markers in kidney renal clear cell carcinoma: an in silico and in vitro analysis-based study

K Sheikh, KN Memon, H Usman… - American Journal of …, 2023 - ncbi.nlm.nih.gov
Background: Kidney renal clear cell carcinoma (KIRC) is the most prevalent type of renal cell
carcinoma (RCC), with a high incidence and mortality rate. There is a lack of sensitive …

[HTML][HTML] Novel hematopoietic progenitor kinase 1 inhibitor KHK-6 enhances T-cell activation

MJ Ahn, EH Kim, Y Choi, CH Chae, P Kim, SH Kim - Plos one, 2024 - journals.plos.org
Inhibiting the functional role of negative regulators in immune cells is an effective approach
for developing immunotherapies. The serine/threonine kinase hematopoietic progenitor …

Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors

F Musumeci, M Sanna, C Greco… - Expert Opinion on …, 2017 - Taylor & Francis
Introduction: Btk is a tyrosine kinase dysregulated in several B-cell malignancies and
autoimmune diseases, and this has given rise to a search for Btk inhibitors. Nevertheless …

[HTML][HTML] Identification of prognostic biomarkers associated with tumor microenvironment in ceRNA network for esophageal squamous cell carcinoma: a bioinformatics …

D Song, Y Wei, Y Hu, X Chen, Y Zheng, M Liu… - Discover Oncology, 2021 - Springer
Background Esophageal squamous cell carcinoma (ESCC) is the most common histological
type of esophageal cancer in the world with high incidence rate and poor prognosis …